0001640334-24-000488.txt : 20240326 0001640334-24-000488.hdr.sgml : 20240326 20240326161017 ACCESSION NUMBER: 0001640334-24-000488 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240326 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BODY & MIND INC. CENTRAL INDEX KEY: 0001715611 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981319227 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55940 FILM NUMBER: 24783615 BUSINESS ADDRESS: STREET 1: 750 - 1095 WEST PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 2M6 BUSINESS PHONE: 604-376-3567 MAIL ADDRESS: STREET 1: 750 - 1095 WEST PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 2M6 FORMER COMPANY: FORMER CONFORMED NAME: DEPLOY TECHNOLOGIES INC DATE OF NAME CHANGE: 20170825 8-K 1 bmmj_8k.htm FORM 8-K bmmj_8k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

March 26, 2024

Date of Report (Date of earliest event reported)

 

BODY AND MIND INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-55940

 

98-1319227

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

750 – 1095 West Pender Street

Vancouver, British Columbia, Canada

 

V6E 2M6

(Address of principal executive offices)

 

(Zip Code)

 

(800) 361-6312

Registrant’s telephone number, including area code

 

Not applicable.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol (s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).

 

Emerging growth company  ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☒

__________

 

 

 

 

SECTION 2 – FINANCIAL INFORMATION

 

Item 2.02 Results of Operations and Financial Condition.

 

On March 26, 2024, Body and Mind Inc. (the “Company” or “BaM”) issued a news release announcing its financial results for the second quarter of fiscal year 2024 ended January 31, 2024.  The information regarding the financial results for the second fiscal quarter ended January 31, 2024 of the Company contained in Item 7.01 below is responsive to this Item 2.02 and is incorporated into this Item 2.02 by reference.

 

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

SECTION 7 – REGULATION FD

 

Item 7.01 Regulation FD Disclosure.

 

On March 26, 2024, the Company issued a news release to announce financial results for the second quarter of fiscal year 2024 ended January 31, 2024 and to provide shareholders with an operational update. All financial information is provided in U.S. dollars unless otherwise indicated.

 

Q2 FY2024 (ended January 31, 2024) Financial Highlights:

 

 

·

Revenue of $4.4 million in Q2 FY2024, as compared to $4.4 million in Q2 FY2023.

 

·

Net Loss of $0.2 million, as compared to Net Loss of $2.7 million in Q2 FY2023.

 

·

Gross margin improved to 45.7% in Q2 FY2024, as compared 39.9% in Q1 FY2023.

 

·

The Company had 147,686,393 common shares outstanding as of March 25, 2024.

 

Q2 FY 2024 Summary & Comparison to Q2 FY 2023 (in Millions of US$)

 

 

 

 

 

 

 

Q2 FY 2024

 

 

 Q2 FY 2023

 

Revenue

 

$4.4

 

 

$4.4

 

Net Operating Profit (Loss)

 

($0.8)

 

 

($1.4)

 

Net Income/(Loss)

 

($0.2)

 

 

($2.7)

 

 

 
2

 

 

Q2 FY2024 Operational Highlights:

 

 

·

As part of the Company’s continuing effort to focus efforts on its highest return projects in Illinois and New Jersey, entered into a definitive agreement to divest the Company’s Nevada cultivation and production operations for total consideration of $2 million. For more details, see the Company’s press release issued on February 1, 2024.

 

·

Advanced New Jersey state license application in conjunction with BaM Body and Mind Dispensary NJ, Inc. The dispensary facility will be 4,000 square feet with more than 100 parking places for easy access and convenient shopping. Demolition has been completed and the building permit is expected soon.

 

·

 Continued construction on the Lynwood, Illinois dispensary with building interior and exterior almost complete, roadwork approvals in process and exterior excavation mostly completed. The Company expects the Lynwood dispensary to open sometime in the first half of calendar 2024.

 

Management Commentary

 

“The most recent quarter reflects our work to improve financial performance, improve margins and streamline our operations to support building our operations in Illinois and New Jersey,” stated Michael Mills, CEO of Body and Mind. “Nevada’s wholesale pricing challenges and wholesale tax structure made it difficult to see the Company’s Nevada operations generating sufficient profits over the long term when compared with the opportunity presented by taking the proceeds from Nevada’s sale and continuing to build on our Illinois and New Jersey opportunities. We feel the Illinois and New Jersey markets continue to be underserved and offer significant opportunities for revenue growth as we expand our brand and bring our skilled teams to these new markets.”

 

For further details, please see the Company’s recent Form 10-Q filing on EDGAR at www.sec.gov/edgar/search, and the interim financial statements filed on SEDAR+ at www.sedarplus.ca.

 

A copy of the news release is attached as Exhibit 99.1 hereto.

 

The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

 
3

 

 

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit

 

Description

 

 

 

99.1

 

News Release dated March 26, 2024.

 

 

 

104

 

Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

__________

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BODY AND MIND INC.

 

 

DATE: March 26, 2024

By:

/s/ Michael Mills

 

 

 

Michael Mills

 

 

 

President, CEO and Director

 

__________

 

 
5

 

 EX-99.1 2 bmmj_ex991.htm NEWS RELEASE bmmj_ex991.htm

EXHIBIT 99.1

 

 

NEWS RELEASE – For Immediate Dissemination

 

Body and Mind Announces Q2 2024 Financial Results

 

Las Vegas, NV and Vancouver, B.C., Canada (March 26, 2024) – Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operations-focused cannabis company, is pleased to announce its financial results for the second quarter of fiscal year 2024 ended January 31, 2024 and to provide shareholders with an operational update. All financial information is provided in U.S. dollars unless otherwise indicated.

 

Q2 FY2024 (ended January 31, 2024) Financial Highlights:

 

 

·

 Revenue of $4.4 million in Q2 FY2024, as compared to $4.4 million in Q2 FY2023.

 

·

 Net Loss of $0.2 million, as compared to Net Loss of $2.7 million in Q2 FY2023.

 

·

 Gross margin improved to 45.7% in Q2 FY2024, as compared 39.9% in Q1 FY2023.

 

·

 The Company had 147,686,393 common shares outstanding as of March 25, 2024.
 

Q2 FY 2024 Summary & Comparison to Q2 FY 2023 (in Millions of US$)

 

 

 

 

 

 

 

Q2 FY 2024

 

 

Q2 FY 2023

 

Revenue

 

 $ 4.4

 

 

 $ 4.4

 

Net Operating Profit (Loss)

 

($0.8)

 

 

($1.4)

 

Net Income/(Loss)

 

($0.2)

 

 

($2.7)

 

 

Q2 FY2024 Operational Highlights:

 

 

·

As part of the Company’s continuing effort to focus efforts on its highest return projects in Illinois and New Jersey, entered into a definitive agreement to divest the Company’s Nevada cultivation and production operations for total consideration of $2 million. For more details, see the Company’s press release issued on February 1, 2024.

 

·

Advanced New Jersey state license application in conjunction with BaM Body and Mind Dispensary NJ, Inc. The dispensary facility will be 4,000 square feet with more than 100 parking places for easy access and convenient shopping. Demolition has been completed and the building permit is expected soon.

 

·

Continued construction on the Lynwood, Illinois dispensary with building interior and exterior almost complete, roadwork approvals in process and exterior excavation mostly completed. The Company expects the Lynwood dispensary to open sometime in the first half of calendar 2024.

 
 

 

 

Management Commentary

 

“The most recent quarter reflects our work to improve financial performance, improve margins and streamline our operations to support building our operations in Illinois and New Jersey,” stated Michael Mills, CEO of Body and Mind. “Nevada’s wholesale pricing challenges and wholesale tax structure made it difficult to see the Company’s Nevada operations generating sufficient profits over the long term when compared with the opportunity presented by taking the proceeds from Nevada’s sale and continuing to build on our Illinois and New Jersey opportunities. We feel the Illinois and New Jersey markets continue to be underserved and offer significant opportunities for revenue growth as we expand our brand and bring our skilled teams to these new markets.”

 

For further details, please see the Company’s recent Form 10-Q filing on EDGAR at www.sec.gov/edgar/search, and the interim financial statements filed on SEDAR+ at www.sedarplus.ca.

 

About Body and Mind Inc.

 

BaM is an operations-focused cannabis company with active retail operations in Illinois and California and pending retail operations in Illinois and New Jersey. We work daily to increase our market share through delighting customers while also continuing to hone our operational efficiencies to drive profits. We are primarily guided by the metric of return on investment. Currently, we believe the most significant return on investment projects in front of us are successful retail cannabis store launches in Illinois and New Jersey, which augment our existing retail footprint. We also believe that our team’s core operational skillsets will create significant future shareholder value as the cannabis industry matures.

 

Please visit www.bodyandmind.com for more information.

Instagram: @bodyandmindBaM

Twitter: @bodyandmindBaM

 

For further information, please contact:

 

Company Contact:

 

Michael Mills

CEO

Tel: 800-361-6312

ir@bodyandmind.com

 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

 
2

 

 

Safe Harbor Statement

Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as “forward-looking statements”. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.

 

Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.

 

 
3

 

 EX-101.SCH 3 bmmj-20240326.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 bmmj-20240326_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Ex Transition Period Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity Address Country EX-101.CAL 5 bmmj-20240326_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 bmmj-20240326_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 bmmj-20240326_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 bmmj_ex991img1.jpg begin 644 bmmj_ex991img1.jpg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htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 26, 2024
Cover [Abstract]  
Entity Registrant Name BODY AND MIND INC.
Entity Central Index Key 0001715611
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Mar. 26, 2024
Entity Ex Transition Period true
Entity File Number 000-55940
Entity Incorporation State Country Code NV
Entity Tax Identification Number 98-1319227
Entity Address Address Line 1 750 – 1095 West Pender Street
Entity Address City Or Town Vancouver
Entity Address State Or Province BC
Entity Address Postal Zip Code V6E 2M6
City Area Code 800
Local Phone Number 361-6312
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Address Country CA
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 21 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://bodyandmind.com/role/Cover Cover Cover 1 false false All Reports Book All Reports bmmj-20240326.xsd bmmj-20240326_cal.xml bmmj-20240326_def.xml bmmj-20240326_lab.xml bmmj-20240326_pre.xml bmmj_8k.htm http://xbrl.sec.gov/dei/2023 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bmmj_8k.htm": { "nsprefix": "bmmj", "nsuri": "http://bodyandmind.com/20240326", "dts": { "schema": { "local": [ "bmmj-20240326.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "bmmj-20240326_cal.xml" ] }, "definitionLink": { "local": [ "bmmj-20240326_def.xml" ] }, "labelLink": { "local": [ "bmmj-20240326_lab.xml" ] }, "presentationLink": { "local": [ "bmmj-20240326_pre.xml" ] }, "inline": { "local": [ "bmmj_8k.htm" ] } }, "keyStandard": 21, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 22, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 21 }, "report": { "R1": { "role": "http://bodyandmind.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-03-26to2024-03-26", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bmmj_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-03-26to2024-03-26", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bmmj_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r0" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r5" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r0" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://bodyandmind.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r4" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 18 0001640334-24-000488-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001640334-24-000488-xbrl.zip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end XML 20 bmmj_8k_htm.xml IDEA: XBRL DOCUMENT 0001715611 2024-03-26 2024-03-26 iso4217:USD shares iso4217:USD shares 0001715611 false 8-K 2024-03-26 BODY AND MIND INC. NV 000-55940 98-1319227 750 – 1095 West Pender Street Vancouver BC CA V6E 2M6 800 361-6312 false false false false true true